Pharm - vyalev
Ended Awarded Last action
- Contract number
- 36C26026F0020
- Awardee
-
Abbvie US LLC UEI MAB9Y43Z1US6
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $41,534
Award facts
- Contract value 100% obligated
- $41,533.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lenexa, KS 66219, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$123,216 | |
| Original award | $164,749 |
About this award
AbbVie US LLC has been awarded a delivery order valued at $41,533.68 for the supply of VYALEV (levodopa-carbidopa suspension), a specialized pharmaceutical treatment for Parkinson's disease. This firm fixed-price contract is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is funded by the Department of Veterans Affairs through Veterans Integrated Service Network 20. The delivery order is scheduled for completion by September 30, 2026, with performance to be executed in Shawnee, Kansas. This award represents a task order drawn from AbbVie US LLC's $15 million Blanket Purchase Agreement with the VA National Acquisition Center, which was established specifically to streamline the procurement of DUOPA and VYALEV medications through July 31, 2026.
The award reflects AbbVie US LLC's established position as a primary federal supplier of specialized Parkinson's disease medications to the VA healthcare system. As a subsidiary of the global biopharmaceutical company AbbVie Inc., the contractor maintains multiple significant indefinite delivery/indefinite quantity contracts with federal healthcare agencies, including a $12.1 billion Federal Supply Schedule contract for pharmaceuticals and drugs. No set-aside designation was applied to this competitive procurement, positioning AbbVie US LLC as an open-market contractor serving the VA's critical pharmaceutical supply needs across its medical center network.
Quick answers
Who was awarded contract 36C26026F0020?
36C26026F0020 was awarded to Abbvie US LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C26026F0020 worth?
The government has obligated $41,534 on 36C26026F0020.
Is contract 36C26026F0020 an order under another contract?
Yes. 36C26026F0020 is a delivery order under 36F79725D0156, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26026F0020 competed?
The extent of competition for 36C26026F0020 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award